|
|
|
|
|
|
|
|
|
News | News By Subject |
News By Date | Search News
|
Print
Email
HST Global, Inc. (HSTC) Announces Continued Success with Dr. Forsythe's "FIT" Protocol
3/9/2010
HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc., (OTCBB: HSTC) today announced that Dr. James Forsythe, MD, HMD, is experiencing continuous success with his Forsythe Immune Therapy (FIT) Protocol. Dr. James Forsythe, MD, HMD, is a board certified oncologist and a member of HST Global Inc.’s Board of Directors and Scientific Advisory Board.
|
|
Read Article at |
Related Companies |
News Categories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|